Clinical Effectiveness of Gluten Immunogenic Peptides During Follow-Up of Coeliac Disease
This is an observational, retrospective, longitudinal, between-groups study design. The authors collected clinical data from patients who had GIP measurement during follow-up from January 2017–June 2021. A descriptive and comparative analysis was performed using SPSS software (IBM, Armonk, New York, USA). The primary objective was to evaluate the clinical effectiveness of GIP measurement during follow-up of patients with coeliac disease. The secondary objective was to analyse the relation between GIP levels and demographic data (gender and age), laboratory results, and histopathology.